ICUI Earnings & Financial Statements
ICU Medical, Inc.
$154.41
-$1.63(-1.04%)
47
Overall
60
Value
30
Tech
52
Quality
Market Cap
$3.90B
Volume
10.16K
52W Range
$112.50 - $192.85
Target Price
$195.57
ICUI earnings and financial statements: ICU Medical, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ICUI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| Cost of revenue | $1.41B | $1.56B | $1.52B | $1.58B | $824.82M |
| Operating income | $42.83M | $42.96M | $22.82M | -$42.90M | $123.25M |
| EBITDA | $310.37M | $277.40M | $274.42M | $248.95M | $257.72M |
| Net income | $732.0K | -$117.69M | -$29.66M | -$74.29M | $103.14M |
| EPS (diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B |
| Total liabilities | $1.93B | $2.24B | $2.26B | $2.43B | $264.71M |
| Shareholders’ equity | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B |
| Cash and equivalents | - | - | - | $208.78M | $552.83M |
| Long-term debt | $1.27B | $1.53B | $1.58B | $1.62B | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $179.85M | $204.03M | $166.20M | -$62.13M | $267.54M |
| Capital expenditure | -$88.96M | -$89.46M | -$93.67M | -$99.33M | -$81.17M |
| Free cash flow | $82.83M | $113.83M | $72.53M | -$161.46M | $186.37M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ICUI | $154.41 | -1.0% | 10.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |